High death rate from neoplasms in French diabetic and non-diabetic men

Lancet. 1998 May 16;351(9114):1512. doi: 10.1016/S0140-6736(05)78903-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Case-Control Studies
  • Clofibrate / adverse effects*
  • Clofibrate / therapeutic use
  • Diabetes Mellitus / mortality*
  • Humans
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / adverse effects*
  • Hypolipidemic Agents / therapeutic use
  • Male
  • Neoplasms / mortality*
  • Paris / epidemiology

Substances

  • Hypolipidemic Agents
  • Clofibrate